Latest News
OpenEvidence Partners with SSO, Pushes AI Deeper into Cancer Surgery
OpenEvidence partners with the Society of Surgical Oncology to integrate clinical content into its AI platform and launch a $100,000 grant for surgeon-led research.
Nextpower Surges After Q4 Beat, Raised Guidance Boosts Platform Narrative
Nextpower shares surged 10% after hours following Q4 results that topped estimates and a raised fiscal 2027 revenue outlook, fueling investor confidence in its platform expansion.
United Flight Attendants Ratify Deal with 31% Pay Hike and Boarding Compensation
United Airlines flight attendants ratified a five-year contract with a 31% base-pay increase, boarding pay, and $741 million in retroactive wages, ending a lengthy negotiation.
Oklo Shares Slide as Q1 Loss Triples, Cash Hoard Tops $2.5 Billion
Oklo reported a Q1 net loss of $33.1 million, more than triple last year, as R&D and admin costs surged. The company holds $2.54 billion in cash but has no reactor revenue.
QuantumScape Surges on $11M Billings, Eagle Line Progress
QuantumScape shares gained 4.9% Tuesday after reporting $11M in Q1 customer billings and progress at its Eagle Line pilot facility, signaling a step toward commercial solid-state battery production.
SELLAS Stock Surges as REGAL Trial Nears Final Analysis
SELLAS Life Sciences shares rose after hours as its REGAL leukemia trial recorded 78 of 80 events needed for final analysis. The company reported a Q1 net loss of $8.4 million but has $107.1 million in cash.
BAT Shares Surge on FDA Policy Shift and Legal Resolution
British American Tobacco shares rose 5.82% in London after the FDA signaled a softer stance on e-cigarette enforcement and a U.S. judge dismissed a North Korea sanctions case.
Oscar Health Shares Surge as Focus Shifts to Margin Strength
Oscar Health shares rose 7.9% to $23.73 late Tuesday as investors prioritized strong profit margins over a Q1 revenue miss, with the medical loss ratio improving to 70.5%.
Zebra Technologies Surges on Strong Q1 Results and Upgraded Forecast
Shares of Zebra Technologies climbed 11.5% after Q1 earnings beat estimates and the company raised its full-year guidance, pointing to a rebound in automation demand.
Ernexa Therapeutics Soars 58% on Ovarian Cancer Therapy Hopes
Ernexa Therapeutics surged 58.5% on Tuesday after renewed investor interest in its preclinical ovarian-cancer cell therapy ERNA-101, though funding concerns persist.